The examination of the driver gene mutation was performed in 45 patients with non-small cell lung cancer who had received the first-generation EGFR-TKIs, and 25 (55.6%) were positive for EGFR T790M mutation. This evidence concerns the gene EGFR and non-small cell lung carcinoma.